517 related articles for article (PubMed ID: 34576134)
1. Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
Ferro M; de Cobelli O; Vartolomei MD; Lucarelli G; Crocetto F; Barone B; Sciarra A; Del Giudice F; Muto M; Maggi M; Carrieri G; Busetto GM; Falagario U; Terracciano D; Cormio L; Musi G; Tataru OS
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576134
[TBL] [Abstract][Full Text] [Related]
2. Radiogenomics in prostate cancer evaluation.
Thenault R; Gasmi A; Khene ZE; Bensalah K; Mathieu R
Curr Opin Urol; 2021 Jul; 31(4):424-429. PubMed ID: 34009176
[TBL] [Abstract][Full Text] [Related]
3. Impact of radiomics on prostate cancer detection: a systematic review of clinical applications.
Sugano D; Sanford D; Abreu A; Duddalwar V; Gill I; Cacciamani GE
Curr Opin Urol; 2020 Nov; 30(6):754-781. PubMed ID: 32941257
[TBL] [Abstract][Full Text] [Related]
4. Radiomics and radiogenomics of prostate cancer.
Smith CP; Czarniecki M; Mehralivand S; Stoyanova R; Choyke PL; Harmon S; Turkbey B
Abdom Radiol (NY); 2019 Jun; 44(6):2021-2029. PubMed ID: 29926137
[TBL] [Abstract][Full Text] [Related]
5. Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review.
Horvat N; Bates DDB; Petkovska I
Abdom Radiol (NY); 2019 Nov; 44(11):3764-3774. PubMed ID: 31055615
[TBL] [Abstract][Full Text] [Related]
6. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
[TBL] [Abstract][Full Text] [Related]
7. Radiogenomics influence on the future of prostate cancer risk stratification.
Banerjee V; Wang S; Drescher M; Russell R; Siddiqui MM
Ther Adv Urol; 2022; 14():17562872221125317. PubMed ID: 36160762
[TBL] [Abstract][Full Text] [Related]
8. The role of radiomics in prostate cancer radiotherapy.
Delgadillo R; Ford JC; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Strahlenther Onkol; 2020 Oct; 196(10):900-912. PubMed ID: 32821953
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer.
Wang J; Wu CJ; Bao ML; Zhang J; Wang XN; Zhang YD
Eur Radiol; 2017 Oct; 27(10):4082-4090. PubMed ID: 28374077
[TBL] [Abstract][Full Text] [Related]
10. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
[TBL] [Abstract][Full Text] [Related]
11. Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.
Alongi P; Stefano A; Comelli A; Laudicella R; Scalisi S; Arnone G; Barone S; Spada M; Purpura P; Bartolotta TV; Midiri M; Lagalla R; Russo G
Eur Radiol; 2021 Jul; 31(7):4595-4605. PubMed ID: 33443602
[TBL] [Abstract][Full Text] [Related]
12. Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study.
Hu L; Zhou DW; Fu CX; Benkert T; Jiang CY; Li RT; Wei LM; Zhao JG
Eur Radiol; 2021 Mar; 31(3):1760-1769. PubMed ID: 32935192
[TBL] [Abstract][Full Text] [Related]
13. MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer.
Zhu X; Shao L; Liu Z; Liu Z; He J; Liu J; Ping H; Lu J
J Zhejiang Univ Sci B; 2023 Aug; 24(8):663-681. PubMed ID: 37551554
[TBL] [Abstract][Full Text] [Related]
14. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric MRI and radiomics in prostate cancer: a review.
Sun Y; Reynolds HM; Parameswaran B; Wraith D; Finnegan ME; Williams S; Haworth A
Australas Phys Eng Sci Med; 2019 Mar; 42(1):3-25. PubMed ID: 30762223
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
18. Beyond diagnosis: is there a role for radiomics in prostate cancer management?
Stanzione A; Ponsiglione A; Alessandrino F; Brembilla G; Imbriaco M
Eur Radiol Exp; 2023 Mar; 7(1):13. PubMed ID: 36907973
[TBL] [Abstract][Full Text] [Related]
19. Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects.
Chaddad A; Tan G; Liang X; Hassan L; Rathore S; Desrosiers C; Katib Y; Niazi T
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568655
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based analysis of [
Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
